GE (NYSE:GE) announced that its GE HealthCare subsidiary closed an offering of senior notes worth $8.5 billion. The company earlier this month announced the offering in connection with the planned spinoff of GE HealthCare. It anticipates the spinoff to go through in the first week of January 2023. According to a news release, GE’s offering […]
GE Healthcare
GE Healthcare donates $1M in ultrasound and monitoring equipment to Ukraine
GE HealthCare announced today that it made a donation of ultrasound and monitoring equipment worth $1 million to Ukraine. The company said it made the donation in support of the country as the ongoing war takes a toll on its healthcare system. The donation includes patient monitors and handheld and stationary ultrasound devices, according to […]
GE HealthCare investing $80M in contrast media ingredients plant in Norway
GE HealthCare today announced it is investing $80 million to expand contrast media production capacity in Norway. The investment will go toward increasing manufacturing capacity by 30% at its active pharmaceutical ingredients site in Lindesnes, Norway. As a result, the investment will create around 100 new jobs. GE HealthCare officials have committed to addressing the […]
GE offering $8.25 billion in notes to help finance GE HealthCare spinoff
GE (NYSE:GE) announced today that it is offering $8.25 billion in senior notes in connection with its planned spinoff of GE HealthCare. The spinoff remains on track to take place during the first week of January 2023. It’s common for companies spinning out of larger parents to start out with debt. For example, spine and […]
GE posts mixed-bag Q3 results as GE HealthCare spinoff remains on track
GE (NYSE: GE) this week posted third-quarter results that beat the revenue consensus on Wall Street but missed on earnings. GE HealthCare spinoff plans remain on track for an early January 2023 completion. The Boston-based company reported a loss of -21¢ per share for the three months ended Sept. 30, 2022, versus a profit of […]
GE Healthcare, AMC Health partner on remote monitoring
GE Healthcare announced today that it partnered with AMC Health to offer remote patient monitoring (RPM) as a virtual care solution. The collaboration allows clinicians to offer RPM virtually to extend patient care outside the hospital to the home environment. They aim to combine GE Healthcare’s acute patient monitoring capabilities in the hospital with AMC’s […]
GE HealthCare moves to secure contrast media supply
GE HealthCare today announced a long-term agreement with Chile-based mining company SQM to secure its supply of iodine for vital imaging agents. The chemical element is a key ingredient for contrast media products. Health providers worldwide use contrast media in X-Ray and Computed Tomography (CT) procedures. The medtech giant is seeking to stabilize contrast media […]
GE HealthCare spinoff moves forward
GE (NYSE: GE) has filed a Form 10 registration statement with the SEC as aims toward completing a GE HealthCare spinoff in early 2023. With $17.6 billion in annual revenue and 51,000 employees, GE HealthCare will remain a major medtech business. (Check out our recent Medtech Big 100 report on the world’s largest medical device […]
FDA clears next-gen deep learning MRI software from GE Healthcare
GE Healthcare (NYSE:GE) announced today that it received FDA 510(k) clearance for its AIR Recon DL for 3D and Propeller imaging sequences. Air Recon DL’s benefits extend to nearly all magnetic resonance imaging (MRI) clinical procedures. The platform covers all anatomies, enabling better image quality, shorter scan times and improved patient experience. GE Healthcare said […]
GE Healthcare, Wayra partner with startups to improve digital health across EMEA
GE Healthcare (NYSE:GE) and Wayra today announced a collaboration to name seven medtech startups to the Edison Accelerator program. The seven startups represent the second cohort of the Edison Accelerator in Europe, the Middle East and Africa (EMEA). The accelerator is a startup and scale-up program designed by GE Healthcare in partnership with UK-based Wayra. […]
GE Healthcare, Lantheus radiotracer trial meets endpoints
GE Healthcare (NYSE:GE) and Lantheus Holdings (NSDQ:LNTH) today announced positive trial results for an investigational radiotracer. The Phase III clinical trial for the Flurpiridaz radiotracer met its co-primary endpoints. It exceeded a 60% threshold for both sensitivity and specificity in detecting coronary artery disease (CAD). GE and Lantheus shared the results at the American Society […]